Mick, Antonia http://orcid.org/0000-0002-5205-7397
Wecker, Hannah http://orcid.org/0000-0002-4097-4518
Ziehfreund, Stefanie http://orcid.org/0000-0003-3176-1120
Maul, Julia-Tatjana http://orcid.org/0000-0002-9914-1545
Biedermann, Tilo http://orcid.org/0000-0002-5352-5105
Zink, Alexander http://orcid.org/0000-0001-9313-6588
Funding for this research was provided by:
Technische Universität München
Article History
Received: 21 November 2023
Revised: 18 January 2024
Accepted: 6 February 2024
First Online: 14 March 2024
Declarations
:
: Antonia M. Mick, Hannah Wecker, and Stefanie Ziehfreund have no conflict of interest do declare. Julia- Tatjana Maul has served as advisor and/or received speaking fees and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, BMS, Celgene, Eli Lilly, Incyte, LEO Pharma, Janssen-Cilag, MSD, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi, UCB. Tilo Biedermann gave advice to or got an honorarium for talks or research grant from the following companies: AbbVie, Alk-Abelló, Celgene-BMS, Lilly Deutschland GmbH, Mylan, Novartis, Phadia-Thermo Fisher, p-95 for Curevac, Sanofi-Genzyme, Regeneron, Viatris. AZ has been an advisor and/or received speaker's honoraria and/or received grants and/or participated in clinical trials from/of the following companies: AbbVie, ALK Abello, Almirall, Amgen, Beiersdorf Dermo Medical, Bencard Allergie, BMS, Celgene, Eli Lilly, GSK, Incyte, Janssen Cilag, Leo Pharma, Miltenyi Biotec, MSD, Novartis, Pfizer, Sanofi-Aventis, Takeda Pharma, Thermo Fisher Scientific Phadia, UCB.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Faculty of Medicine at the Technical University of Munich (248/20 S).
: Informed written consent was obtained from all individual participants included in the study.
: Not applicable.